The Online Investor

Slideshow Secondary Stock Offerings

By The Online Investor Staff, updated Sun., Apr. 5, 2:42 PM

Slide #1. Invitae Corporation Secondary Offering

Company: Invitae Corporation (NYSE:NVTA)
Date announced: 4/1/2020
Shares Offered: 17,777,778
Date of Pricing: 4/1/2020
Price Per Share: $9.00
Secondary Offering Details: Invitae Corporation (NYSE: NVTA) today announced that it has commenced an underwritten public offering of $125.0 million of shares of its common stock, before deducting underwriting discounts and commissions and other offering expenses. All of the shares are being offered by Invitae. In addition, Invitae expects to grant the underwriters a 30-day option to purchase up to an additional $18.75 million of shares of its common stock at the public offering price, less underwriting discounts and commissions. The offering is subject to market and other conditions, and there can be no assurance as to whether or when the offering may be completed, or as to the actual size or terms of the offering. -updated 4/2- Invitae Corporation (NYSE: NVTA) today announced the pricing of an underwritten public offering of 17,777,778 shares of its common stock at a price to the public of $9.00 per share. All of the shares are being sold by Invitae. The gross proceeds to Invitae from the offering, before deducting the underwriting discounts and commissions and other offering expenses, are expected to be approximately $160.0 million. The offering is expected to close on or about April 6, 2020, subject to customary closing conditions. In addition, Invitae has granted the underwriters a 30-day option to purchase up to an additional 2,666,666 shares of its common stock at the public offering price, less underwriting discounts and commissions.

Invitae is engaged in genetic testing services that support patient care throughout life's journey from inherited disease diagnosis, to family planning, to health screening with a network of patients, healthcare providers, biopharma and advocacy partners. Co.'s tests include genes associated with hereditary cancer, neurological disorders, cardiovascular disorders, pediatric disorders, metabolic disorders and other hereditary conditions. In addition, Co.'s services also include screening and testing in reproductive health, including preimplantation and carrier screening for inherited disorders, prenatal diagnosis, miscarriage analysis and pediatric developmental disorders.

NVTA SEC Filing Email Alerts Service

Open the NVTA Page at The Online Investor »

Company Name: 
Invitae Corp
Website: 
www.invitae.com
Sector: 
Diagnostics
Number of ETFs Holding NVTA: 
21
Total Market Value Held by ETFs: 
$90.05M
Total Market Capitalization: 
$1.16B
% of Market Cap. Held by ETFs: 
7.77%
 

Open the NVTA Page at The Online Investor (in a new window) »

List of Secondary Stock Offerings in this Slideshow:

2/20/2020:
Company: EyePoint Pharmaceuticals, Inc. (EYPT)
Shares Offered: 15,000,000
More: offering details »

2/20/2020:
Company: Agile Therapeutics, Inc. (AGRX)
Shares Offered: 15,000,000
More: offering details »

2/20/2020:
Company: Universal Technical Institute, Inc. (UTI)
Shares Offered: 6,782,610
More: offering details »

2/20/2020:
Company: BioSig Technologies, Inc. (BGSM)
Shares Offered: 2,500,000
More: offering details »

2/20/2020:
Company: Gladstone Land Corporation (LAND)
Shares Offered: 400,000
More: offering details »

2/20/2020:
Company: Gladstone Commercial Corporation (GOOD)
Shares Offered: 20,000,000
More: offering details »

2/20/2020:
Company: Document Security Systems, Inc. (DSS)
Shares Offered: 22,222,223
More: offering details »

2/25/2020:
Company: Freshpet, Inc. (FRPT)
Shares Offered: 3,478,260
More: offering details »

2/26/2020:
Company: Realty Income Corporation (O)
Shares Offered: 9,000,000
More: offering details »

2/27/2020:
Company: Oramed Pharmaceuticals Inc. (ORMP)
Shares Offered: 5,250,000
More: offering details »

2/27/2020:
Company: Digital Ally, Inc. (DGLY)
Shares Offered: 2,521,740
More: offering details »

2/28/2020:
Company: TONIX PHARMACEUTICALS, INC. (TNXP)
Shares Offered: 14,550,000
More: offering details »

3/2/2020:
Company: Karyopharm Therapeutics Inc. (KPTI)
Shares Offered: 6,250,000
More: offering details »

3/2/2020:
Company: eHealth, Inc. (EHTH)
Shares Offered: 1,800,000
More: offering details »

3/3/2020:
Company: Zogenix, Inc. (ZGNX)
Shares Offered: 8,520,000
More: offering details »

3/4/2020:
Company: Medicenna Therapeutics Corp. (MDNA.CA)
Shares Offered: 11,290,323
More: offering details »

3/4/2020:
Company: Keurig Dr Pepper (KDP)
Shares Offered: 40,000,000
More: offering details »

3/11/2020:
Company: Compugen Ltd. (CGEN)
Shares Offered: 8,333,334
More: offering details »

3/11/2020:
Company: Seelos Therapeutics, Inc. (SEEL)
Shares Offered: 7,500,000
More: offering details »

3/23/2020:
Company: Hoth Therapeutics Inc. (HOTH)
Shares Offered: 1,449,275
More: offering details »

3/25/2020:
Company: Alexco Resource Corp. (AXU)
Shares Offered: 4,054,500
More: offering details »

3/27/2020:
Company: The Howard Hughes Corporation (HHC)
Shares Offered: 2,000,000
More: offering details »

3/30/2020:
Company: Agree Realty Corporation (ADC)
Shares Offered: 2,500,000
More: offering details »

3/30/2020:
Company: Carnival Corporation & plc (CCL)
More: offering details »

4/1/2020:
Company: Invitae Corporation (NVTA)
Shares Offered: 17,777,778
More: offering details »

Quotes delayed 20 minutes



Strong Buy (3.71 out of 4)
74th percentile
(ranked higher than approx. 74% of all stocks covered)
Based on Zacks ABR data;
powered by Xignite

Secondary Stock Offerings Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2020, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.